cucurbitacins has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, Y; Liu, A; Liu, Q; Shen, H; Tian, M; Xu, D; Ying, M; Zhang, H; Zhang, X | 1 |
1 other study(ies) available for cucurbitacins and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Cucurbitacin C suppresses the progression of pancreatic ductal adenocarcinoma via inhibition of the cGMP-PKG-VASP axis.
Topics: Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cucurbitacins; Epithelial-Mesenchymal Transition; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Pancreatic Neoplasms | 2023 |